(4) Yu and colleagues [86] used bisulfite sequencing to profile 30 CRC tumors and 19 lymph node metastases to ultimately identify DNA methylation of LBX2 as a biomarker of metastasis that outperforms CEA and imaging testing. This evidence concerns the gene CEACAM5 and colorectal carcinoma.